Physician profile
Lawrence F Simon
NPI 1710045281
$1,075.89
in general payments reported to CMS, 2019-2025
22 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $75.34 · 2021: $16.25 · 2022: $79.36 · 2023: $110 · 2024: $103 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.06 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $229.78 | 2019-2020 | |
| Organogenesis INC. | $168.18 | 2025 | Puraply Wound Matrix |
| Astrazeneca Pharmaceuticals LP | $143.90 | 2019-2025 | Imfinzi |
| Smith+Nephew, INC. | $103.66 | 2019-2023 | Grafix Pl, Renasys Go V2 Home, Pico |
| Boston Scientific Corporation | $86.22 | 2024 | Exalt Model D |
| Portola Pharmaceuticals, LLC | $28.51 | 2019 | |
| Olympus America INC. | $27.93 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $25.62 | 2019 | |
| Convatec INC. | $24.48 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.54 | 2019-2020 | |
| Bioventus LLC | $22.65 | 2022 | |
| Davol INC. | $22.38 | 2022 | |
| Bsn Medical INC | $21.53 | 2022 | |
| Thd America, INC. | $20.00 | 2019 | |
| Ethicon US, LLC | $19.89 | 2023 | Pds, Vicryl, Monocryl |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.02 | 2019 | |
| Medtronic, INC. | $17.23 | 2023 | Endo Gia Ultra |
| Solventum Corporation | $16.47 | 2024 | Promogran Prisma, 3m Coban, Activ.A.C. |
| Medline Industries LP | $16.25 | 2021 | |
| Merck Sharp & Dohme LLC | $14.33 | 2020 | |
| Axonics, INC. | $12.80 | 2022 | |
| Polarityte, INC. | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.